debrisoquin has been researched along with diazoxide in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Petrie, JC | 1 |
Khattri, HN; Wahi, PL | 1 |
Sternon, J | 1 |
Palkoski, Z; Pettinger, W; Renyi, E; Sheppard, H | 1 |
O'Brien, BW | 1 |
Muldowney, FP | 1 |
9 other study(ies) available for debrisoquin and diazoxide
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Diseases of the cardiovascular system Hypertension--II.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bethanidine; Clonidine; Debrisoquin; Diazoxide; Drug Therapy, Combination; Guanethidine; Humans; Hydralazine; Methyldopa; Phytotherapy; Piperazines; Plants, Medicinal; Quinazolines; Rauwolfia | 1976 |
Drug treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Debrisoquin; Diazoxide; Diuretics; Female; Humans; Hypertension; Male; Methyldopa; Pargyline; Secologanin Tryptamine Alkaloids | 1976 |
[The practitioner and drug-induced, predominantly orthostatic hypotension].
Topics: Adrenergic Agents; Adrenergic Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Antipsychotic Agents; Barbiturates; Butyrophenones; Clonidine; Debrisoquin; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypotension, Orthostatic; Levodopa; Meprobamate; Methyldopa; Mineralocorticoids; Monoamine Oxidase Inhibitors; Phenothiazines; Prazosin; Psychotropic Drugs; Reserpine; Vasodilator Agents | 1978 |
Angiotensin antagonism and antihypertensive activity of phosphodiesterase inhibiting agents.
Topics: Adult; Angiotensin II; Animals; Bethanechol Compounds; Blood Pressure; Bradykinin; Bretylium Compounds; Debrisoquin; Diazoxide; Dose-Response Relationship, Drug; Female; Guanethidine; Heart Rate; Humans; Hydralazine; Imidazoles; Male; Norepinephrine; Phenoxybenzamine; Phentolamine; Phosphodiesterase Inhibitors; Rats; Theophylline; Vasodilator Agents | 1973 |
The management of essential hypertension.
Topics: Antihypertensive Agents; Benzyl Compounds; Debrisoquin; Diazoxide; Diuretics; Guanidines; Humans; Hypertension; Methyldopa; Pentolinium Tartrate; Posture; Propranolol; Sodium Chloride Symporter Inhibitors; Sulfates; United Kingdom | 1974 |
Management of severe hypertension.
Topics: Chlorthalidone; Coma; Debrisoquin; Diazoxide; Guanethidine; Humans; Hypertension, Malignant; Methyldopa; Nephrectomy; Pentolinium Tartrate; Renal Dialysis; Vomiting | 1972 |